$KURA

$9.91▼ -4.16% YTD

8 SEC 13D/G filings tracked · Last updated Oct 27, 2026

Filing History

KURA - Kura Oncology, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks Simplified

$9.91▼ -4.16%Oct 27, 2026 · ThinkSabio Blog

$KURA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #KURA Kura Oncology, Inc. : $9.91 Sector: Healthcare | YTD: 🔽 -4…

News

KURA ▲ +0.4% - Kura Oncology, Inc.

CP $10.44▲ +0.4%Oct 13, 2026 · ThinkSabio Blog

$KURA - Caspian Therapeutics and Kura Oncology Outline KO-7246 Development Strategy in Diabetes…

News

KURA ▼ -0.8% - Kura Oncology, Inc.

CP $10.45▲ -0.8%Oct 7, 2026 · ThinkSabio Blog

$KURA - Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes…

News

KURA ▲ +2.3% - Kura Oncology, Inc.

CP $10.95▲ +2.3%Oct 1, 2026 · ThinkSabio Blog

$KURA int Overweight @ JPM pt 30…

News

KURA ▲ +0.6% - Kura Oncology, Inc.

CP $10.70▲ +0.6%Sep 29, 2026 · ThinkSabio Blog

$KURA - Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes…

News

KURA ▲ +0.9% - Kura Oncology, Inc.

CP $12.64▲ +0.9%Sep 9, 2026 · ThinkSabio Blog

$KURA - Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach f…

News

KURA ▲ +0.2% - Kura Oncology, Inc.

CP $13.28▲ +0.2%Sep 8, 2026 · ThinkSabio Blog

$KURA - Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer…

News

KURA ▲ +0.3% - Kura Oncology, Inc.

CP $13.16▲ +0.3%Sep 4, 2026 · ThinkSabio Blog

$KURA - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…